IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3′ dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro

This publication has 10 references indexed in Scilit:

• In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets
  Cancer Immunology, Immunotherapy, 1987
• Partial purification of murine B cell stimulatory factor (BSF)-1.
  The Journal of Immunology, 1985
• Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
  Nature, 1985
• The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.
  The Journal of Immunology, 1984
• T‐T Cell Interactions during Cytotoxic T Lymphocyte (CTL) Responses: T Cell Derived Helper Factor (Interleukin 2) as a Probe to Analyze CTL Responsiveness and Thymic Maturation of CTL Progenitors
  Immunological Reviews, 1980
• Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC)
  Cellular and Molecular Life Sciences, 1978
• Drug Induced Modulation of Immune Responses in Mice: Effects of 5-(3,3-Dimethyl-1-Triazeno)-Imidazole-4-Carboxamide (DTIC) and Cyclophosphayide (CY)
  Journal of Immunopharmacology, 1978
• Kinetic Analysis of Target Cell Destruction by Effector T Cells
  The Journal of Immunology, 1976
• Cellular immune response to a drug-treated L5178Y lymphoma subline
  Nature, 1974
• VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS
  The Journal of Experimental Medicine, 1967